This website is no longer updated

The Swiss National COVID-19 Science Task Force was dissolved on 31 March 2022.

It has been replaced by the Scientific Advisory Panel to ensure that the cantons and the Confederation can continue to benefit from scientific expertise in the context of the SARS-CoV-2 pandemic.

This website is therefore no longer updated, but its content remains accessible as an archive.

General

Speech by Tanja Stadler at the Point de presse, 22 March 2022

Original text in German Sehr geehrte Damen und Herren, Mesdames et Messieurs, Die Pandemie ist noch nicht vorbei, doch es herrscht in der Schweiz keine akute Krisensituation mehr. Die Schweiz geht in vielen Bereichen von den Krisenstrukturen in reguläre Strukturen über, welche die langfristige Herausforderungen durch SARS-CoV-2 mit einbeziehen müssen.  Zu diesem Übergang  gehört auch, […]

Speech by Tanja Stadler at the Point de presse, 22 March 2022 Read More

The mandate of the Swiss National COVID-19 Science Task Force ends on March 31, 2022.
16 February 2022

The peak of the omicron wave has passed. A high level of immunity now exists in the population. In particular, protection in the population against severe disease is currently high. Switzerland is gradually returning from crisis mode to regular structures.  “The Science Task Force has always said that the goal is to no longer be

The mandate of the Swiss National COVID-19 Science Task Force ends on March 31, 2022.
16 February 2022
Read More

Statement Prof. Alain di Gallo, at the Point de presse, 4 January 2022

Original text in German Sehr geehrte Damen und Herren, Mesdames et Messieurs Die SARS-CoV-2 Delta-Variante hat bereits im Herbst einen massiven Anstieg der Infektionen in den jüngsten Altersgruppen verursacht. Nun verbreitet sich die noch stärker übertragbare Omikron-Variante in der Bevölkerung. Als die am wenigsten oder noch gar nicht geimpfte Gruppe werden Kinder stark von der

Statement Prof. Alain di Gallo, at the Point de presse, 4 January 2022 Read More

Statement Prof. Samia Hurst, at the Point de presse, 4 January 2022

Original text in German Meine Damen und Herren, Mesdames et Messieurs Vor zwei Jahren berichtete die WHO von mehreren Fällen schwerer Lungenentzündungen in der chinesischen Provinz Hubei. Bereits eine Woche später wurde die Gensequenz des Virus online veröffentlicht. Elf Monate später wurde die erste Person geimpft. Mittlerweile haben fast 60 % der Weltbevölkerung mindestens eine

Statement Prof. Samia Hurst, at the Point de presse, 4 January 2022 Read More

Measures in Schools

Joint statement from the Swiss National COVID-19 Science Task Force, Pédiatrie Suisse and Kinderärzte Schweiz Context The SARS-CoV-2 Delta variant has caused an unprecedented surge in infections in the pediatric population. This is most likely related to the increased affinity of the Delta variant for the ACE-2 receptor[1], thereby increasing susceptibility to infection, especially in

Measures in Schools Read More

Speech by Tanja Stadler at the Point de presse, 28 December 2021

Original text in German Sehr geehrte Damen und Herren, Mesdames et Messieurs, Der erste bestätigte Omikron Fall in der Schweiz wurde in einer Probe von vor 5 Wochen gefunden. Inzwischen gehen mehr Infektionen auf Omikron als auf Delta zurück. Das wissen wir aus Labordaten der städtischen Regionen um Zürich, Genf und Bellinzona, aus schweizweiten Sequenzierungsdaten

Speech by Tanja Stadler at the Point de presse, 28 December 2021 Read More

Tanja Stadler’s term as president of the Swiss National COVID-19 Science Task Force extended

At the end of 2021 Switzerland, again finds itself in a critical phase of the pandemic. Very high infection rates and low population immunity to the highly contagious delta variant are putting the healthcare system under pressure. At the same time, the new omicron variant is spreading worldwide at a rapid rate.  In this tense

Tanja Stadler’s term as president of the Swiss National COVID-19 Science Task Force extended Read More

Speech by Tanja Stadler at the Point de presse, 29 November 2021

Original text in German Sehr geehrte Damen und Herren, Mesdames et Messieurs, Seit Ende letzter Woche ist eine neue Variante bekannt: B.1.1.529 oder wie sie von der Weltgesundheitsorganisation WHO am vergangenen Freitag benannt wurde, Omikron. Heute möchte ich darlegen, was zu dieser Variante bekannt ist, was noch nicht bekannt ist, und was das aus wissenschaftlicher

Speech by Tanja Stadler at the Point de presse, 29 November 2021 Read More

New President: Tanja Stadler takes the leadership of the Swiss National COVID-19 Science Task Force

Currently, about half of the Swiss population is fully vaccinated with the highly effective vaccines from Pfizer/BioNTech or Moderna. After the Federal Council announced the “normalization phase” at its media conference on August 11, 2021, the organization of the Swiss National COVID-19 Science Task Force is also adapting. Together with the transition into the “normalization

New President: Tanja Stadler takes the leadership of the Swiss National COVID-19 Science Task Force Read More

«Swiss National COVID-19 Science Task Force»: New organization as of summer 2021

The Swiss vaccination programme is progressing rapidly, and the epidemiological situation is developing positively. In order to adapt to the new situation and changing needs, the Task Force will be reorganised and downsized this summer. Prof. Martin Ackermann will hand over the Task Force leadership to Prof. Tanja Stadler. This transition will take place as

«Swiss National COVID-19 Science Task Force»: New organization as of summer 2021 Read More

This website is no longer updated

The Swiss National COVID-19 Science Task Force was dissolved on 31 March 2022.

It has been replaced by the Scientific Advisory Panel to ensure that the cantons and the Confederation can continue to benefit from scientific expertise in the context of the SARS-CoV-2 pandemic.

This website is therefore no longer updated, but its content remains accessible as an archive.